{"transactions":[{"id":2494169,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Committee Chairman"}}],"security":"W Warrants","published_at":"2021-11-26T17:01:25.000Z","date":"2021-11-23","kind":"other","acquired":false,"shares":3000000,"ownership":{"direct":false,"nature":"HCFP/Capital Partners 18B-2 LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person is a member and co-manager of HCFP/Capital Partners 18B-2 LLC (\"HCFP 18B-2\"). On November 23, 2021, HCFP 18B-2, pursuant to a Warrant Contribution Agreement by and between the Issuer and HCFP 18B-2, agreed to contribute its 3,000,000 W Warrants back to the Company in exchange for the Company cancelling a $1.5 million contingent promissory note, including any and all interest, owed by HCFP 18B-2 to the Company."}],"balance_after":0,"derivative":{"exercise_price":4,"exercise_date":"2021-10-01","expiration_date":"2026-09-30","underlying":"B Unit","underlying_shares":3000000},"source":{"system":"sec-edgar","filing":"0001104659-21-144011","document":"tm2133885-2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000110465921144011/tm2133885-2_4.xml","form_type":"4"}},{"id":2586550,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Committee Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-08-30T09:11:15.000Z","date":"2021-08-27","kind":"purchase","acquired":true,"shares":790,"price":4.98,"value":3934.2,"ownership":{"direct":false,"nature":"HCFP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.96 to $5.00 per share inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Greenspan is deemed to have shared voting and dispositive power over HCFP-held securities. Mr. Greenspan disclaims beneficial ownership of shares by this entity, except to the extent of his proportionate pecuniary interest therein."}],"balance_after":14640,"source":{"system":"sec-edgar","filing":"0001104659-21-110764","document":"tm2126537-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000110465921110764/tm2126537-1_4.xml","form_type":"4"}},{"id":2586549,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Committee Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-08-30T09:11:15.000Z","date":"2021-08-27","kind":"purchase","acquired":true,"shares":110,"price":4.92,"value":541.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.91 to $5.00 per share inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":82450,"source":{"system":"sec-edgar","filing":"0001104659-21-110764","document":"tm2126537-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000110465921110764/tm2126537-1_4.xml","form_type":"4"}},{"id":2590799,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Committee Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-08-25T08:15:28.000Z","date":"2021-08-24","kind":"purchase","acquired":true,"shares":50,"price":4.65,"value":232.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.50 to $4.70 per share inclusive. The Reporting\nPerson undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of\nshares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":82340,"source":{"system":"sec-edgar","filing":"0001104659-21-109182","document":"tm2125834-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000110465921109182/tm2125834-1_4seq1.xml","form_type":"4"}},{"id":2590798,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Committee Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-08-25T08:15:28.000Z","date":"2021-08-23","kind":"purchase","acquired":true,"shares":500,"price":4.41,"value":2205.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.38 to $4.45 per share inclusive. The Reporting\nPerson undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of\nshares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":82290,"source":{"system":"sec-edgar","filing":"0001104659-21-109182","document":"tm2125834-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000110465921109182/tm2125834-1_4seq1.xml","form_type":"4"}},{"id":2593493,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Committee Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-08-23T08:24:04.000Z","date":"2021-08-20","kind":"purchase","acquired":true,"shares":400,"price":4.23,"value":1692.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.22 to $4.25 per share inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":81790,"source":{"system":"sec-edgar","filing":"0001104659-21-108376","document":"tm2125683d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000110465921108376/tm2125683d1_4.xml","form_type":"4"}},{"id":2593492,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Committee Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-08-23T08:24:04.000Z","date":"2021-08-19","kind":"purchase","acquired":true,"shares":2000,"price":4.04,"value":8080.0,"ownership":{"direct":false,"nature":"HCFP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.02 to $4.10 per share inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Greenspan is deemed to have shared voting and dispositive power over HCFP-held securities. Mr. Greenspan disclaims beneficial ownership of shares by this entity, except to the extent of his proportionate pecuniary interest therein."}],"balance_after":13850,"source":{"system":"sec-edgar","filing":"0001104659-21-108376","document":"tm2125683d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000110465921108376/tm2125683d1_4.xml","form_type":"4"}},{"id":2596123,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Committee Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-08-19T18:10:39.000Z","date":"2021-08-18","kind":"purchase","acquired":true,"shares":1000,"price":4.27,"value":4270.0,"ownership":{"direct":false,"nature":"HCFP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Greenspan is deemed to have shared voting and dispositive power over HCFP-held securities. Mr. Greenspan disclaims beneficial ownership of shares by this entity, except to the extent of his proportionate pecuniary interest therein."}],"balance_after":11850,"source":{"system":"sec-edgar","filing":"0001104659-21-107826","document":"tm2125455-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000110465921107826/tm2125455-1_4seq1.xml","form_type":"4"}},{"id":2596122,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Committee Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-08-19T18:10:39.000Z","date":"2021-08-17","kind":"purchase","acquired":true,"shares":1000,"price":4.13,"value":4130.0,"ownership":{"direct":false,"nature":"HCFP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.10 to $4.18 per share inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Greenspan is deemed to have shared voting and dispositive power over HCFP-held securities. Mr. Greenspan disclaims beneficial ownership of shares by this entity, except to the extent of his proportionate pecuniary interest therein."}],"balance_after":10850,"source":{"system":"sec-edgar","filing":"0001104659-21-107826","document":"tm2125455-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000110465921107826/tm2125455-1_4seq1.xml","form_type":"4"}},{"id":2617530,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Committee Chairman"}}],"security":"W Warrants","published_at":"2021-08-03T18:50:07.000Z","date":"2021-07-31","kind":"other","acquired":true,"shares":1068016,"ownership":{"direct":false,"nature":"SCPS/Strategic Capital Partners LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents W Warrants held by SCPS/Strategic Capital Partners LLC, of which Mr. Greenspan is a co-manager. Accordingly, he is deemed to have shared voting and dispositive power over the securities held by such entity. Mr. Greenspan disclaims beneficial ownership of such securities, except to the extent of his proportionate pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents W Warrants held by SCPS/Strategic Capital Partners LLC, of which Mr. Greenspan is a co-manager. Accordingly, he is deemed to have shared voting and dispositive power over the securities held by such entity. Mr. Greenspan disclaims beneficial ownership of such securities, except to the extent of his proportionate pecuniary interest therein."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each W Warrant is exercisable for one B Unit. Starting on April 1, 2022, each B Unit can be separated into one share of common stock and one Z Warrant. Each Z Warrant is exercisable for one share of common stock with an exercise price of $5.00 per share. The Z Warrant will become exercisable on July 1, 2022 and will expire on June 30, 2027."}],"balance_after":1068016,"derivative":{"exercise_price":4,"exercise_date":"2021-10-01","expiration_date":"2026-09-30","underlying":"B Unit","underlying_shares":1068016},"source":{"system":"sec-edgar","filing":"0001104659-21-099627","document":"tm2123824d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000110465921099627/tm2123824d1_4.xml","form_type":"4"}},{"id":2623777,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Committee Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-07-27T16:59:36.000Z","date":"2021-07-27","kind":"purchase","acquired":true,"shares":200,"price":4.54,"value":908.0,"ownership":{"direct":true},"balance_after":81390,"source":{"system":"sec-edgar","filing":"0001104659-21-096344","document":"tm2123355-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000110465921096344/tm2123355-2_4seq1.xml","form_type":"4"}},{"id":2623776,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Committee Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-07-27T16:59:36.000Z","date":"2021-07-26","kind":"purchase","acquired":true,"shares":400,"price":4.76,"value":1904.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.74 to $4.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (4) to this Form 4."}],"balance_after":81190,"source":{"system":"sec-edgar","filing":"0001104659-21-096344","document":"tm2123355-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000110465921096344/tm2123355-2_4seq1.xml","form_type":"4"}},{"id":2623775,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Committee Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-07-27T16:59:36.000Z","date":"2021-07-26","kind":"purchase","acquired":true,"shares":1000,"price":4.78,"value":4780.0,"ownership":{"direct":false,"nature":"HCFP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.78 to $4.79 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Greenspan is deemed to have shared voting and dispositive power over HCFP-held securities. Mr. Greenspan disclaims beneficial ownership of shares by this entity, except to the extent of his proportionate pecuniary interest therein."}],"balance_after":9850,"source":{"system":"sec-edgar","filing":"0001104659-21-096344","document":"tm2123355-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000110465921096344/tm2123355-2_4seq1.xml","form_type":"4"}},{"id":2623774,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Committee Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-07-27T16:59:36.000Z","date":"2021-07-23","kind":"purchase","acquired":true,"shares":1100,"price":4.77,"value":5247.0,"ownership":{"direct":false,"nature":"HCFP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.72 to $4.95 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Greenspan is deemed to have shared voting and dispositive power over HCFP-held securities. Mr. Greenspan disclaims beneficial ownership of shares by this entity, except to the extent of his proportionate pecuniary interest therein."}],"balance_after":8850,"source":{"system":"sec-edgar","filing":"0001104659-21-096344","document":"tm2123355-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000110465921096344/tm2123355-2_4seq1.xml","form_type":"4"}},{"id":2829545,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Committee Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-02-26T13:21:58.000Z","date":"2021-02-25","kind":"purchase","acquired":true,"shares":800,"price":9.01,"value":7208.0,"ownership":{"direct":false,"nature":"HCFP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.00 to $9.02 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Greenspan is deemed to have shared voting and dispositive power over HCFP-held securities. Mr. Greenspan disclaims beneficial ownership of shares by this entity, except to the extent of his proportionate pecuniary interest therein."}],"balance_after":7750,"source":{"system":"sec-edgar","filing":"0001104659-21-028948","document":"tm218062d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000110465921028948/tm218062d1_4seq1.xml","form_type":"4"}},{"id":2829544,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Committee Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-02-26T13:21:58.000Z","date":"2021-02-24","kind":"purchase","acquired":true,"shares":300,"price":9.45,"value":2835.0,"ownership":{"direct":false,"nature":"HCFP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.44 to $9.46 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Greenspan is deemed to have shared voting and dispositive power over HCFP-held securities. Mr. Greenspan disclaims beneficial ownership of shares by this entity, except to the extent of his proportionate pecuniary interest therein."}],"balance_after":6950,"source":{"system":"sec-edgar","filing":"0001104659-21-028948","document":"tm218062d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000110465921028948/tm218062d1_4seq1.xml","form_type":"4"}},{"id":2829543,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Committee Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-02-26T13:21:58.000Z","date":"2021-02-24","kind":"purchase","acquired":true,"shares":115,"price":9.48,"value":1090.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.44 to $9.69 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":80790,"source":{"system":"sec-edgar","filing":"0001104659-21-028948","document":"tm218062d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000110465921028948/tm218062d1_4seq1.xml","form_type":"4"}},{"id":2835757,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Committee Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-02-24T07:46:07.000Z","date":"2021-02-23","kind":"purchase","acquired":true,"shares":1300,"price":9.66,"value":12558.0,"ownership":{"direct":false,"nature":"HCFP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.50 to $9.90 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Greenspan is deemed to have shared voting and dispositive power over HCFP-held securities. Mr. Greenspan disclaims beneficial ownership of shares by this entity, except to the extent of his proportionate pecuniary interest therein."}],"balance_after":6650,"source":{"system":"sec-edgar","filing":"0001104659-21-027147","document":"tm217761-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000110465921027147/tm217761-1_4seq1.xml","form_type":"4"}},{"id":2835756,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Committee Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-02-24T07:46:07.000Z","date":"2021-02-23","kind":"purchase","acquired":true,"shares":200,"price":9.58,"value":1916.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.36 to $9.95 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":80675,"source":{"system":"sec-edgar","filing":"0001104659-21-027147","document":"tm217761-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000110465921027147/tm217761-1_4seq1.xml","form_type":"4"}},{"id":2839139,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Committee Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-02-23T07:55:10.000Z","date":"2021-02-22","kind":"purchase","acquired":true,"shares":450,"price":10.05,"value":4522.5,"ownership":{"direct":false,"nature":"HCFP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.86 to $10.22 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Greenspan is deemed to have shared voting and dispositive power over HCFP-held securities. Mr. Greenspan disclaims beneficial ownership of shares by this entity, except to the extent of his proportionate pecuniary interest therein."}],"balance_after":5350,"source":{"system":"sec-edgar","filing":"0001104659-21-026463","document":"tm217579d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000110465921026463/tm217579d1_4seq1.xml","form_type":"4"}},{"id":2849974,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Committee Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-02-18T21:22:15.000Z","date":"2021-02-18","kind":"purchase","acquired":true,"shares":2200,"price":10.04,"value":22088.0,"ownership":{"direct":false,"nature":"HCFP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.60 to $10.35 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (5) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Greenspan is deemed to have shared voting and dispositive power over HCFP-held securities. Mr. Greenspan disclaims beneficial ownership of shares held by this entity, except to the extent of his proportionate pecuniary interest therein."}],"balance_after":4900,"source":{"system":"sec-edgar","filing":"0001104659-21-025419","document":"tm217163-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000110465921025419/tm217163-1_4seq1.xml","form_type":"4"}},{"id":2849973,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Committee Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-02-18T21:22:15.000Z","date":"2021-02-17","kind":"purchase","acquired":true,"shares":200,"price":9.81,"value":1962.0,"ownership":{"direct":false,"nature":"HCFP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"These shares were purchased in multiple transactions at a price of $9.81 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Greenspan is deemed to have shared voting and dispositive power over HCFP-held securities. Mr. Greenspan disclaims beneficial ownership of shares held by this entity, except to the extent of his proportionate pecuniary interest therein."}],"balance_after":2700,"source":{"system":"sec-edgar","filing":"0001104659-21-025419","document":"tm217163-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000110465921025419/tm217163-1_4seq1.xml","form_type":"4"}},{"id":2849972,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Committee Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-02-18T21:22:15.000Z","date":"2021-02-17","kind":"purchase","acquired":true,"shares":475,"price":9.69,"value":4602.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.49 to $10.26 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":80475,"source":{"system":"sec-edgar","filing":"0001104659-21-025419","document":"tm217163-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000110465921025419/tm217163-1_4seq1.xml","form_type":"4"}},{"id":2849971,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Committee Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-02-18T21:22:15.000Z","date":"2021-02-16","kind":"purchase","acquired":true,"shares":2500,"price":10.2,"value":25500.0,"ownership":{"direct":false,"nature":"HCFP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.15 to $10.30 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Greenspan is deemed to have shared voting and dispositive power over HCFP-held securities. Mr. Greenspan disclaims beneficial ownership of shares held by this entity, except to the extent of his proportionate pecuniary interest therein."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001104659-21-025419","document":"tm217163-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000110465921025419/tm217163-1_4seq1.xml","form_type":"4"}},{"id":3898344,"issuer":{"id":7317,"kind":"organization","name":"PAVmed Inc."},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-11T17:33:13.000Z","date":"2018-06-08","kind":"sale","acquired":false,"shares":18300,"price":1.04,"value":19032.0,"ownership":{"direct":true},"balance_after":421691,"source":{"system":"sec-edgar","filing":"0001144204-18-033789","document":"tv496281_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000114420418033789/tv496281_4.xml","form_type":"4"}},{"id":3905188,"issuer":{"id":7317,"kind":"organization","name":"PAVmed Inc."},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T20:46:43.000Z","date":"2018-06-01","kind":"sale","acquired":false,"shares":532255,"price":0.97,"value":516287.35,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Includes sales of common stock in open market transactions between 6/1/2018 and 6/5/2018."}],"balance_after":439991,"source":{"system":"sec-edgar","filing":"0001144204-18-032917","document":"tv495849_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000114420418032917/tv495849_4.xml","form_type":"4"}},{"id":4058045,"issuer":{"id":7317,"kind":"organization","name":"PAVmed Inc."},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-14T15:41:49.000Z","date":"2017-12-21","kind":"other","acquired":true,"shares":846984,"ownership":{"direct":false,"nature":"By HCFP Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects 846,984 shares of Common Stock that were previously held through HCFP/Capital Partners LLC, and became directly held on December 21, 2017. Mr. Greenspan is Chairman and Chief Executive Officer of this entity, and shares voting and dispositive power over the shares held by this entity. Mr. Greenspan disclaims beneficial ownership of shares held by this entity, except to the extent of his proportionate pecuniary interest therein."}],"balance_after":846984,"source":{"system":"sec-edgar","filing":"0001144204-18-008836","document":"tv486024_5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000114420418008836/tv486024_5.xml","form_type":"5"}},{"id":4058044,"issuer":{"id":7317,"kind":"organization","name":"PAVmed Inc."},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-14T15:41:49.000Z","date":"2017-12-21","kind":"other","acquired":false,"shares":5646562,"ownership":{"direct":false,"nature":"By HCFP/Capital Partners III LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of Common Stock were distributed pro rata by such entity to its equity holders for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Greenspan is a member and Co-Manager of HCFP/Capital Partners III LLC, and shares joint voting and dispositive power over the shares held by this entity. Mr. Greenspan disclaims beneficial ownership of shares held by this entity, except to the extent of his proportionate pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-18-008836","document":"tv486024_5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000114420418008836/tv486024_5.xml","form_type":"5"}},{"id":4058043,"issuer":{"id":7317,"kind":"organization","name":"PAVmed Inc."},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-02-14T15:41:49.000Z","date":"2017-12-21","kind":"gift","acquired":false,"shares":246000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects 1,523,781 shares of Common Stock that were previously held through HCFP/Capital Partners LLC, and became directly held on December 21, 2017."}],"balance_after":1306246,"source":{"system":"sec-edgar","filing":"0001144204-18-008836","document":"tv486024_5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000114420418008836/tv486024_5.xml","form_type":"5"}},{"id":4140340,"issuer":{"id":7317,"kind":"organization","name":"PAVmed Inc."},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2017-12-06T16:42:12.000Z","date":"2017-11-22","kind":"other","acquired":false,"shares":67317,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By HCFP/Capital Partners III LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The securities were contributed to an affiliated entity and then distributed pro rata by such entity to its equity holders."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Greenspan is a member and a co-manager of HCFP/Capital Partners III LLC, and shares joint voting and dispositive power over the shares held by this entity. Mr. Greenspan disclaims beneficial ownership of shares held by this entity, except to the extent of his proportionate pecuniary interest therein."}],"balance_after":5646562,"derivative":{"exercise_price":5,"exercise_date":"2016-10-28","expiration_date":"2022-01-29","underlying":"Common Stock","underlying_shares":5646562},"source":{"system":"sec-edgar","filing":"0001144204-17-062636","document":"tv480886_4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000114420417062636/tv480886_4a.xml","form_type":"4/A","original_submission_date":"2017-11-27"}},{"id":4140339,"issuer":{"id":7317,"kind":"organization","name":"PAVmed Inc."},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-06T16:42:12.000Z","date":"2017-11-22","kind":"other","acquired":false,"shares":67317,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By HCFP/Capital Partners III LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The securities were contributed to an affiliated entity and then distributed pro rata by such entity to its equity holders."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Greenspan is a member and a co-manager of HCFP/Capital Partners III LLC, and shares joint voting and dispositive power over the shares held by this entity. Mr. Greenspan disclaims beneficial ownership of shares held by this entity, except to the extent of his proportionate pecuniary interest therein."}],"balance_after":5646562,"source":{"system":"sec-edgar","filing":"0001144204-17-062636","document":"tv480886_4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000114420417062636/tv480886_4a.xml","form_type":"4/A","original_submission_date":"2017-11-27"}},{"id":4150879,"issuer":{"id":7317,"kind":"organization","name":"PAVmed Inc."},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2017-11-27T18:04:36.000Z","date":"2017-11-22","kind":"other","acquired":false,"shares":67317,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By HCFP/Capital Partners III LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The securities were contributed to an affiliated entity and then distributed pro rata by such entity to its equity holders."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Greenspan is a member and a co-manager of HCFP/Capital Partners III LLC, and shares joint voting and dispositive power over the shares held by this entity. Mr. Greenspan disclaims beneficial ownership of shares held by this entity, except to the extent of his proportionate pecuniary interest therein."}],"balance_after":5646562,"derivative":{"exercise_price":5,"exercise_date":"2016-10-28","expiration_date":"2022-01-29","underlying":"Common Stock","underlying_shares":5646562},"source":{"system":"sec-edgar","filing":"0001094891-17-000277","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000109489117000277/edgar.xml","form_type":"4"}},{"id":4150878,"issuer":{"id":7317,"kind":"organization","name":"PAVmed Inc."},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-11-27T18:04:36.000Z","date":"2017-11-22","kind":"other","acquired":false,"shares":67317,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By HCFP/Capital Partners III LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The securities were contributed to an affiliated entity and then distributed pro rata by such entity to its equity holders."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Greenspan is a member and a co-manager of HCFP/Capital Partners III LLC, and shares joint voting and dispositive power over the shares held by this entity. Mr. Greenspan disclaims beneficial ownership of shares held by this entity, except to the extent of his proportionate pecuniary interest therein."}],"balance_after":5646562,"source":{"system":"sec-edgar","filing":"0001094891-17-000277","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000109489117000277/edgar.xml","form_type":"4"}},{"id":4448808,"issuer":{"id":7317,"kind":"organization","name":"PAVmed Inc."},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2017-02-14T19:08:29.000Z","date":"2016-12-09","kind":"other","acquired":true,"shares":320,"price":6.774,"value":2167.68,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $5.9875 to $7.4900, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants acquired at each separate price within the ranges set forth in this footnote."}],"balance_after":28293,"derivative":{"exercise_price":5,"exercise_date":"2016-10-28","expiration_date":"2022-01-29","underlying":"Common Stock","underlying_shares":320},"source":{"system":"sec-edgar","filing":"0001094891-17-000068","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000109489117000068/edgar.xml","form_type":"5"}},{"id":4448807,"issuer":{"id":7317,"kind":"organization","name":"PAVmed Inc."},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2017-02-14T19:08:29.000Z","date":"2016-11-18","kind":"other","acquired":true,"shares":100,"price":7.9,"value":790.0,"ownership":{"direct":true},"balance_after":28293,"derivative":{"exercise_price":5,"exercise_date":"2016-10-28","expiration_date":"2022-01-29","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001094891-17-000068","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000109489117000068/edgar.xml","form_type":"5"}},{"id":4448806,"issuer":{"id":7317,"kind":"organization","name":"PAVmed Inc."},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-02-14T19:08:29.000Z","date":"2016-12-09","kind":"other","acquired":true,"shares":282,"price":8.4719,"value":2389.0758,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $7.6780 to $8.9990, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote."}],"balance_after":28465,"source":{"system":"sec-edgar","filing":"0001094891-17-000068","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000109489117000068/edgar.xml","form_type":"5"}},{"id":4448805,"issuer":{"id":7317,"kind":"organization","name":"PAVmed Inc."},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-02-14T19:08:29.000Z","date":"2016-11-23","kind":"other","acquired":true,"shares":110,"price":8.9867,"value":988.537,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $8.5535 to $9.0300, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote."}],"balance_after":28465,"source":{"system":"sec-edgar","filing":"0001094891-17-000068","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000109489117000068/edgar.xml","form_type":"5"}},{"id":4448804,"issuer":{"id":7317,"kind":"organization","name":"PAVmed Inc."},"owners":[{"id":133077,"kind":"person","name":"Greenspan Ira Scott","position":1,"cik":"0001449211","reported_name":"Greenspan Ira Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-02-14T19:08:29.000Z","date":"2016-11-18","kind":"other","acquired":true,"shares":200,"price":10.2,"value":2040.0,"ownership":{"direct":true},"balance_after":28465,"source":{"system":"sec-edgar","filing":"0001094891-17-000068","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1449211/000109489117000068/edgar.xml","form_type":"5"}}]}